Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening [NA]
A completed study evaluating whether a printed decision aid influences patients' intentions to undergo prostate cancer screening.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy [Phase 2]
Phase 2 clinical trial investigating methylphenidate hydrochloride to reduce fatigue in prostate cancer patients receiving hormone therapy w…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD [Phase 3]
This update notes the completion of a Phase IIIb trial comparing intermittent versus continuous hormone deprivation therapy with ELIGARD (go…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating AMG 162 for bone loss in men undergoing androgen-deprivation therapy for non-metastatic prostate cancer has complet…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) [Phase 1]
A Phase 1 clinical trial update for the V934/V935 cancer vaccine (V934-002) in selected solid tumors; the study is completed and results hav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: A Trial of Degarelix in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating degarelix in prostate cancer has completed. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy [Phase 4]
This clinical trial update reports termination of a Phase 4 randomized trial comparing robotic-assisted and open radical prostatectomy for p…
-
FDA label_change · 2014-05-30FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals. This notice relates to regulatory ac…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg [Phase 2]
A Phase 2 trial comparing intramuscular versus subcutaneous administration of long-acting Pamorelin (triptorelin) shows equivalence for trea…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating vorinostat for progressive metastatic prostate cancer has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer [Phase 1]
A Phase 1 study of CNTO 328 (siltuximab) in patients with metastatic hormone-refractory prostate cancer has completed.
-
FDA approval · 2014-05-23FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for XTANDI (enzalutamide) filed by Astellas Pharma US, expanding the labeling for the drug.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife [Phase 2]
Phase 2 clinical trial update on SPARC, evaluating stereotactic prostate ablative radiotherapy using the CyberKnife device for prostate canc…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Comparison of Different Inspiratory to Expiratory Ratios on Respiratory Mechanics and Oxygenation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum [NA]
A completed clinical trial evaluating different inspiratory-to-expiratory ratios on respiratory mechanics and oxygenation during robot-assis…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. [Phase 2]
Phase 2 trial evaluating a three-drug combination of estramustine, docetaxel, and carboplatin in patients with hormone-refractory prostate c…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 1]
Phase 1 trial assessing the safety and preliminary activity of doxorubicin plus estramustine in patients with metastatic prostate cancer; th…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer [Phase 2]
Phase II trial evaluating metronomic dosing of etoposide and cyclophosphamide in prostate cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy [NA]
A pilot clinical trial evaluated sonoelastography to plan tumor-targeted biopsy for prostate cancer. The study was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Phase II Study of BI 2536 in Prostate Cancer [Phase 2]
A Phase II study of BI-2536 in prostate cancer has completed.
-
FDA approval · 2014-05-15FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Docetaxel (Sanofi-Aventis U.S. LLC), indicating an approved modification to its labeling and…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy [NA]
ClinicalTrials.gov entry updating a study that compares MRI fusion biopsy techniques in men with elevated PSA and a prior negative prostate …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation [Phase 4]
This Phase 4 clinical trial evaluates the efficacy and safety of dutasteride (Avodart) in men with prostate cancer undergoing seed implantat…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men [Phase 1]
Phase 1 study assessing how severe hepatic impairment affects the metabolism, safety, and tolerability of a single oral dose of enzalutamide…
-
FDA approval · 2014-05-13FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ZYTIGA (abiraterone acetate) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen [Phase 2]
Phase 2 trial evaluating sipuleucel-T manufactured with different concentrations of PA2024 antigen in prostate cancer; results completed and…